Загрузка...
Targeting of BCL-2 Family Members during Anticancer Treatment: A Necessary Compromise between Individual Cell and Ecosystemic Responses?
The imbalance between BCL-2 homologues and pro-death counterparts frequently noted in cancer cells endows them with a cell autonomous survival advantage. To eradicate ectopic cells, inhibitors of these homologues (BH3 mimetics) were developed to trigger, during anticancer treatment, full activation...
Сохранить в:
| Опубликовано в: : | Biomolecules |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7464802/ https://ncbi.nlm.nih.gov/pubmed/32722518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10081109 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|